These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3739555)

  • 1. The local administration of relaxin induces changes in the microcirculation of the rat mesocaecum.
    Bigazzi M; Del Mese A; Petrucci F; Casali R; Novelli GP
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):296-9. PubMed ID: 3739555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB.
    Dschietzig T; Bartsch C; Richter C; Laule M; Baumann G; Stangl K
    Circ Res; 2003 Jan; 92(1):32-40. PubMed ID: 12522118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of relaxin on the microvasculature of mouse mammary gland.
    Bani G; Bani Sacchi T; Bigazzi M; Bianchi S
    Histol Histopathol; 1988 Oct; 3(4):337-43. PubMed ID: 2980242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin is a potent renal vasodilator in conscious rats.
    Danielson LA; Sherwood OD; Conrad KP
    J Clin Invest; 1999 Feb; 103(4):525-33. PubMed ID: 10021461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis.
    Santora K; Rasa C; Visco D; Steinetz BG; Bagnell CA
    J Pharmacol Exp Ther; 2007 Aug; 322(2):887-93. PubMed ID: 17526806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis.
    Ho TY; Santora K; Chen JC; Frankshun AL; Bagnell CA
    Bone; 2011 Jun; 48(6):1346-53. PubMed ID: 21419242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective antagonism of hormone-induced vasoconstriction by synthetic atrial natriuretic factor in the rat microcirculation.
    Proctor KG; Bealer SL
    Circ Res; 1987 Jul; 61(1):42-9. PubMed ID: 2955950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxin, a potent microcirculatory effector, is not angiogenic.
    Norrby K; Bani D; Bigazzi M; Banni Sacchi T
    Int J Microcirc Clin Exp; 1996; 16(5):227-31. PubMed ID: 8951520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of rat skin flap viability by relaxin-expressing adenovirus.
    Lee WJ; Yun CO; Yun IS; Kim YO; Choi IK; Yun TJ; Rah DK
    Wound Repair Regen; 2011 Nov; 19(6):709-17. PubMed ID: 22092841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin Ameliorates Renal Fibrosis and Expression of Endothelial Cell Transition Markers in Rats of Isoproterenol-Induced Heart Failure.
    Zheng G; Cai J; Chen X; Chen L; Ge W; Zhou X; Zhou H
    Biol Pharm Bull; 2017; 40(7):960-966. PubMed ID: 28674260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor inhibits basal and stimulated relaxin secretion by cultured porcine luteal cells: analysis by reverse hemolytic plaque assay.
    Taylor MJ; Clark CL
    Endocrinology; 1992 Apr; 130(4):1951-6. PubMed ID: 1547722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxin increases rat heart rate by a direct action on the cardiac atrium.
    Ward DG; Thomas GR; Cronin MJ
    Biochem Biophys Res Commun; 1992 Jul; 186(2):999-1005. PubMed ID: 1497682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
    Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
    Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oestrogen and relaxin on uterine and cervical enzymes: collagenase, proteoglycanase and beta-glycuronidase.
    Too CK; Kong JK; Greenwood FC; Bryant-Greenwood GD
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):394-403. PubMed ID: 3008478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin increases the release of plasminogen activator, collagenase, and proteoglycanase from rat granulosa cells in vitro.
    Too CK; Bryant-Greenwood GD; Greenwood FC
    Endocrinology; 1984 Sep; 115(3):1043-50. PubMed ID: 6086281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide in effects of tumor necrosis factor-alpha on microcirculation in rat.
    Baudry N; Vicaut E
    J Appl Physiol (1985); 1993 Dec; 75(6):2392-9. PubMed ID: 8125855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report.
    Garella R; Squecco R; Baccari MC
    Curr Protein Pept Sci; 2017; 18(12):1254-1262. PubMed ID: 28606038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxin-induced increased coronary flow through stimulation of nitric oxide production.
    Bani-Sacchi T; Bigazzi M; Bani D; Mannaioni PF; Masini E
    Br J Pharmacol; 1995 Sep; 116(1):1589-94. PubMed ID: 8564223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of relaxin on the mouse mammary gland. II. The epithelium.
    Bani G; Bigazzi M; Bani D
    J Endocrinol Invest; 1986 Apr; 9(2):145-52. PubMed ID: 3711601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute decrease in progesterone and increase in estrogen secretion caused by relaxin during late pregnancy in beef heifers.
    Musah AI; Schwabe C; Anderson LL
    Endocrinology; 1987 Jan; 120(1):317-24. PubMed ID: 3780565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.